Literature DB >> 22271104

Left atrial volume and function in patients with Behcet's disease assessed by real-time three-dimensional echocardiography.

Erdal Aktürk1, Jülide Yağmur, Ertuğrul Kurtoğlu, Necip Ermis, Nusret Acikgoz, Serpil Sener, Yasin Karakuş, Semra Aktürk, Yelda Karincaoğlu, Hasan Pekdemir, Ramazan Özdemir.   

Abstract

AIMS: Behçet's disease (BD), a multisystemic inflammatory disorder, has been associated with a number of cardiovascular dysfunctions, including endomyocardial fibrosis of the right heart, atrial fibrillation, ventricular arrhythmias and sudden cardiac death. The incidence and nature of cardiac involvement in BD are not yet clearly documented. Our aim was to evaluate left atrial (LA) volume and functions using real-time three-dimensional echocardiography (RT3DE) in Behcet's patients without any cardiac symptom. METHODS AND
RESULTS: The study included 40 BD (16 females, 24 males and mean age of 33±7 years) and 30 healthy (11 females, 19 males and mean age of 35±6 years) subjects. All the patients' demographic parameters such as age, gender, and duration of BD were recorded. All the individuals underwent comprehensive 2D echocardiography examination, and RT3DE was performed to assess LA volumes and mechanical functions. LA maximum volume (Vmax) and before atrial contraction volume (Vpre A), LA active stroke volume and total stroke volumes (TSV), total emptying and active emptying fractions and expansion index were significantly higher in Behcet's disease patients when compared with the controls (P<0.0001 for all). LA passive emptying fraction was significantly lower in the patients with BD than in the controls (41±7 vs. 44±5, P=0.039). There were positive correlations between TSV and high-sensitive C-reactive protein level (r=0.413, P=0.008), TSV, and disease duration (r=0.417, P<0.007).
CONCLUSION: Our study has shown that LA mechanical functions and volumes are impaired in BD. These results may be an early form of subclinical cardiac involvement in patients with BD who have no clinical evidence for cardiovascular disease.

Entities:  

Mesh:

Year:  2012        PMID: 22271104     DOI: 10.1093/ejechocard/jer301

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  6 in total

1.  Behçet's disease: A (silk) route to atrial fibrillation?

Authors:  Santosh V Suryavanshi; Na Li
Journal:  Int J Cardiol       Date:  2019-07-19       Impact factor: 4.164

2.  Assessment of left atrial volume and function in patients with psoriasis by using real time three-dimensional echocardiography.

Authors:  Halil Atas; Alper Kepez; Mehmet Bozbay; Dilek Seckin Gencosmanoglu; Altug Cincin; Murat Sunbul; Ayfer Yildiz Bozbay; Ramila Darvishova; Tulin Ergun
Journal:  Wien Klin Wochenschr       Date:  2015-07-31       Impact factor: 1.704

3.  Cardiac magnetic resonance imaging in patients with Behçet's disease.

Authors:  Ali A Ahmed; Samar Tharwat; Nihal M Batouty; Ahmed El Bahy; Ahmed M Tawfik; Dina A Shahin
Journal:  Adv Rheumatol       Date:  2021-12-07

Review 4.  Cardiac Function and Diastolic Dysfunction in Behcet's Disease: A Systematic Review and Meta-Analysis.

Authors:  Fawad Aslam; Salman J Bandeali; Cynthia Crowson; Mahboob Alam
Journal:  Int J Rheumatol       Date:  2016-05-10

5.  Evaluation of left atrial volume and function in systemic sclerosis patients using speckle tracking and real-time three-dimensional echocardiography.

Authors:  Halil Ataş; Alper Kepez; Kürşat Tigen; Fuad Samadov; Gülsen Özen; Altuğ Cincin; Murat Sünbül; Mehmet Bozbay; Haner Direşkeneli; Yelda Başaran
Journal:  Anatol J Cardiol       Date:  2015-07-03       Impact factor: 1.596

6.  Left atrial dysfunction detected by speckle tracking in patients with systemic sclerosis.

Authors:  Gergely Agoston; Luna Gargani; Marcelo Haertel Miglioranza; Maria Caputo; Luigi Paolo Badano; Antonella Moreo; Denisa Muraru; Sergio Mondillo; Alberto Moggi Pignone; Marco Matucci Cerinic; Rosa Sicari; Eugenio Picano; Albert Varga
Journal:  Cardiovasc Ultrasound       Date:  2014-08-05       Impact factor: 2.062

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.